Janus Henderson Contrarian Fund
Janus Investment Fund · 8 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Janus Henderson Contrarian Fund is an actively managed U.S. equity fund.
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
- Features
- Non-diversified
Fund profile
As filed in the prospectus · 2026 Q1
Janus Henderson Contrarian Fund seeks long-term growth of capital.
The fund pursues long-term capital growth by investing in a portfolio of 35–55 common stocks selected through bottom-up analysis for trading at significant discounts to the manager's estimate of intrinsic value, with expected value growth over time and aligned management teams. The fund is nondiversified, permitting larger positions in individual securities than a diversified fund would hold. Because performance depends on the manager's valuation judgments and the securities selected, results may diverge materially from the broader market. The fund may invest across all market capitalizations and in foreign securities.
| Share class | Gross | Net |
|---|---|---|
| JSVAX | 0.77% | 0.77% |
| JCNAX | 0.90% | 0.90% |
| JCNCX | 1.63% | 1.63% |
| JCONX | 0.63% | 0.63% |
| JCNRX | 1.41% | 1.37% |
| JCNIX | 1.23% | 1.11% |
| JACNX | 0.65% | — |
| JCNNX | 0.53% | 0.53% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 52.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 95.00% |
| Cash & short-term | 5.38% |
| Derivatives | -0.04% |
The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.
Derivatives are shown at market value, not notional exposure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Information Technology | 19.0% |
| International | 17.3% |
| Health Care | 16.3% |
| Financials | 15.4% |
| 5 smaller | 32.0% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +28.62% | +42.31% | +48.57% | 19.23% | -13.76% | |
| +28.44% | +41.70% | +47.59% | 19.19% | -13.80% | |
| +27.67% | +38.86% | +42.53% | 19.21% | -14.05% | |
| +28.81% | +42.78% | +49.54% | 19.22% | -13.72% | |
| +27.87% | +39.77% | +44.20% | 19.24% | -13.96% | |
| +28.18% | +40.89% | +46.09% | 19.21% | -13.88% | |
| +28.81% | +42.74% | +49.42% | 19.22% | -13.73% | |
| +28.94% | +43.34% | +50.40% | 19.26% | -13.65% |
These classes hold the same portfolio, so the 7.87pp spread over 5 years is the cost difference between them — roughly 1.57pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | Nebius Group NV | 5.76% | $276.17 | $316.36M | 1.1M |
| MRVL | Marvell Technology, Inc.MRVL | 5.53% | $297.89 | $303.48M | 1.0M |
| TSM | Taiwan Semiconductor Manufacturing Co. Ltd.TSM | 5.40% | $477.57 | $296.55M | 621.0K |
| — | Janus Henderson Cash Liquidity Fund LLC | 5.07% | — | $278.04M | — |
| PNC | PNC Financial Services Group, Inc. (The)PNC | 4.36% | $246.22 | $238.97M | 970.6K |
| COF | Capital One Financial Corp.COF | 4.35% | $200.62 | $238.84M | 1.2M |
| SGRY | Surgery Partners, Inc.SGRY | 4.06% | $16.80 | $222.74M | 13.3M |
| UNH | UnitedHealth Group, Inc.UNH | 4.05% | $415.63 | $222.52M | 535.4K |
| LITE | Lumentum Holdings, Inc.LITE | 3.98% | $858.06 | $218.30M | 254.4K |
| ORCL | Oracle Corp.ORCL | 3.83% | $146.55 | $210.41M | 1.4M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 46.40% of net assets, top 25 81.67%, across 45 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free